Association study of the BIN1 and IL-6 genes on Alzheimer’s disease

Genome-wide association study (GWAS) has identified several novel genes associated with the risk of Alzheimer's disease (AD), which is a progressive neurodegenerative disease in elders. However, most of the novel genes have not been validated through replication in separated populations. Among them, the BIN1 gene is involved in endocytosis and intracellular trafficking as well as in the formation of β amyloid plaques and neurofibrillary tangles, which are the main pathological hallmarks of AD. The IL-6 gene has also been frequently associated with AD; however, consistent results have not been found. IL-6, a cytokine from the immune system, is implicated in the pathogenesis of several degenerative diseases. Similar to BIN1, it is suggested that IL-6 is also involved in the formation of β amyloid plaques. In this case-control study, we aimed to investigate whether single nucleotide polymorphisms in the BIN1 (rs744373) and IL-6 (rs1800795) genes are associated with AD. Genotype frequencies were evaluated via PCR-RFLP in 82 late-onset AD patients and 159 elderly healthy controls, who were matched by age and gender. In this study, no association was found for either polymorphism, suggesting that these genes are not implicated in the aetiology of AD in all populations.

[1]  T. Dobosz,et al.  Polymorphism 174 G/C of interleukin 6 gene in Alzheimer's disease--preliminary report. , 2008, Neurologia i neurochirurgia polska.

[2]  Claudio Franceschi,et al.  Interleukin-6 gene alleles affect the risk of Alzheimer’s disease and levels of the cytokine in blood and brain , 2003, Neurobiology of Aging.

[3]  F. Licastro,et al.  Interleukin-1β and interleukin-6 gene polymorphisms as risk factors for AD: A prospective study , 2006, Experimental Gerontology.

[4]  J. Lambert,et al.  Genetics of Alzheimer's disease: new evidences for an old hypothesis? , 2011, Current opinion in genetics & development.

[5]  Nick C Fox,et al.  Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes , 2009, Nature Genetics.

[6]  S Rozen,et al.  Primer3 on the WWW for general users and for biologist programmers. , 2000, Methods in molecular biology.

[7]  J. Bidwell,et al.  A novel NlaIII polymorphism in the human IL-6 promoter. , 1998, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[8]  E. Génin,et al.  No replication of genetic association between candidate polymorphisms and Alzheimer's disease , 2011, Neurobiology of Aging.

[9]  R. Lakshmy,et al.  MTHFR (677 and 1298) and IL-6-174 G/C genes in pathogenesis of Alzheimer's and vascular dementia and their epistatic interaction , 2012, Neurobiology of Aging.

[10]  Mingzhi Liao,et al.  BIN1 gene rs744373 polymorphism contributes to Alzheimer's disease in East Asian population , 2013, Neuroscience Letters.

[11]  Karl Pearson F.R.S..  X. On the criterion that a given system of deviations from the probable in the case of a correlated system of variables is such that it can be reasonably supposed to have arisen from random sampling , 2009 .

[12]  L. Tan,et al.  Bridging integrator 1 (BIN1): form, function, and Alzheimer's disease. , 2013, Trends in molecular medicine.

[13]  P. Bertolucci,et al.  Association between interleukin 6 gene haplotype and Alzheimer's disease: a Brazilian case-control study. , 2013, Journal of Alzheimer's disease : JAD.

[14]  M. Owen,et al.  Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology , 2013, Molecular Psychiatry.

[15]  Hilkka Soininen,et al.  Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations , 2011, Neurobiology of Aging.

[16]  A. Quintana,et al.  Interleukin-6, a Major Cytokine in the Central Nervous System , 2012, International journal of biological sciences.

[17]  K. Pearson.  On the Criterion that a Given System of Deviations from the Probable in the Case of a Correlated System of Variables is Such that it Can be Reasonably Supposed to have Arisen from Random Sampling , 1900 .

[18]  Xiping Xu,et al.  Relationship of MTHFR Gene 677C→T Polymorphism, Homocysteine, and Estimated Glomerular Filtration Rate Levels With the Risk of New-Onset Diabetes , 2015, Medicine.

[19]  M. Novák,et al.  No association between cytokine gene polymorphism and risk of Alzheimer's disease in Slovaks. , 2010, Acta neurobiologiae experimentalis.

[20]  M. Neff,et al.  Web-based primer design for single nucleotide polymorphism analysis. , 2002, Trends in genetics : TIG.

[21]  F. Panza,et al.  Interleukin 6–174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease , 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[22]  D. Grattapaglia,et al.  Genetic composition of Brazilian population samples based on a set of twenty‐eight ancestry informative SNPs , 2009, American journal of human biology : the official journal of the Human Biology Council.

[23]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[24]  J. Bauer,et al.  The participation of interleukin-6, a stress-inducible cytokine, in the pathogenesis of Alzheimer's disease , 1996, Behavioural Brain Research.

[25]  E. Camargos,et al.  Cytokine Gene Polymorphisms and Alzheimer's Disease in Brazil , 2013, Neuroimmunomodulation.

[26]  I. Louro,et al.  Protective effect of the APOE-e3 allele in Alzheimer's disease , 2011, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[27]  C. Capurso.  Has dysregulated interleukin-6 gene a role in the development of Alzheimer's disease? , 2011, Neuroscience Letters.

[28]  Lars Lannfelt,et al.  Genetic Analysis of Alzheimer’s Disease in the Uppsala Longitudinal Study of Adult Men , 2009, Dementia and Geriatric Cognitive Disorders.

[29]  E. Keller,et al.  Molecular and cellular biology of interleukin-6 and its receptor. , 1996, Frontiers in bioscience : a journal and virtual library.

[30]  Nick C Fox,et al.  Letter abstract - Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's Disease , 2009 .

[31]  R. Lemos,et al.  The Genetics of Alzheimer’s Disease in Brazil: 10 Years of Analysis in a Unique Population , 2008, Journal of Molecular Neuroscience.

[32]  M. Hutz,et al.  The Genomic Ancestry of Individuals from Different Geographical Regions of Brazil Is More Uniform Than Expected , 2011, PloS one.

[33]  H. Möller,et al.  Interleukin‐6–174 G/C Promoter Gene Polymorphism C Allele Reduces Alzheimer's Disease Risk , 2003, Journal of the American Geriatrics Society.

[34]  T. Klockgether,et al.  An Interleukin-6 Promoter Variant Is Not Associated with an Increased Risk for Alzheimer’s Disease , 2004, Dementia and Geriatric Cognitive Disorders.

[35]  D. Clair,et al.  Interleukin-6 promoter polymorphism: risk and pathology of Alzheimer's disease , 2004, Neuroscience Letters.